IGC Pharma, Inc.
XASE:IGC
0.32
$1.40 - 167.00
$0.30 - 500.00
$0.32
$0.33
$0.33
$0.32
0.5
0.25
294035
363399.3
71300674.97
Chart
TendieTensor AI Analysis
Company
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Fundamentals
70
-4.100000
3.626140
100
BBG000NSSLY8
BBG001SQQKX0
91.96M
91.96M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own IGC. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.